Intron a and Sandostatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Intron a (interferon alfa-2b) and Sandostatin (octreotide acetate). Common drug interactions include blood chromogranin a increased among females and lymphadenopathy among males.

The phase IV clinical study analyzes what interactions people have when they take Intron a and Sandostatin. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Intron a?

Intron a has active ingredients of interferon alfa-2b. eHealthMe is studying from 9,320 Intron a users. Check the latest studies of Intron a.

What is Sandostatin?

Sandostatin has active ingredients of octreotide acetate. It is often used in acromegaly. eHealthMe is studying from 46,793 Sandostatin users. Check the latest studies of Sandostatin.

On Jul, 20, 2026

32 people who take Intron a and Sandostatin together, and have interactions are studied.

Intron a and Sandostatin drug interactions.

What are the common drug interactions of Intron A and Sandostatin, by gender? *:

female:

Blood chromogranin a increased
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Malignant neoplasm progression (cancer tumour came back)
Metastases to lymph nodes (cancer spreads to lymph node)
Neoplasm malignant (cancer tumour)
Disease progression
Fatigue (feeling of tiredness)
Headache (pain in head)
Hepatic pain (pain in liver)
Lymphadenopathy (disease or enlargement of lymph nodes)

male:

Lymphadenopathy (disease or enlargement of lymph nodes)
Decreased appetite
Osteonecrosis of jaw (death of bone of jaw)
Somnolence (a state of near-sleep, a strong desire for sleep)
Weight decreased
Abdominal discomfort
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Anaemia (lack of blood)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Aortic arteriosclerosis (hardening of the aortic arteries)

What are the common drug interactions of Intron A and Sandostatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Decreased appetite
Depression
Drug intolerance (drug sensitivity)
Fatigue (feeling of tiredness)
Hypertension (high blood pressure)
Hypotension (abnormally low blood pressure)
Neuropathy peripheral (surface nerve damage)
Osteonecrosis (death of bone)
Peripheral swelling
Pleural effusion (water on the lungs)

30-39:

Lymphadenopathy (disease or enlargement of lymph nodes)
Disease progression
Metastases to liver (cancer spreads to liver)
Malignant neoplasm progression (cancer tumour came back)
Hepatic mass

40-49:

n/a

50-59:

Blood triglycerides increased
Death
Dementia due to pick's disease (madness due to pick's disease)
Depressed mood
Disease progression
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Lymphadenopathy (disease or enlargement of lymph nodes)
Weight decreased
Hepatic pain (pain in liver)
Abdominal pain

60+:

Abdominal pain
Arthralgia (joint pain)
Back pain
Diarrhoea
Loss of consciousness
Pain
Somnolence (a state of near-sleep, a strong desire for sleep)
Neoplasm malignant (cancer tumour)
Abdominal discomfort
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)

What are the existing conditions these people have? *

Metastases To Lymph Nodes (cancer spreads to lymph node): 4 people, 12.50%
Neuroendocrine Tumor: 3 people, 9.38%
Neuroendocrine Carcinoma (cancer tumour that arise from cells of the endocrine (hormonal) and nervous systems): 3 people, 9.38%
Liver Disorder (liver diseases): 3 people, 9.38%
Osteolysis (dissolution of bone): 2 people, 6.25%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 2 people, 6.25%
Angiopathy (generic term for a disease of the blood vessels): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Intron a and Sandostatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously